Embla Medical hf. (CPH:EMBLA)
Denmark · Delayed Price · Currency is DKK 29.45
+0.10 (0.34%)
Aug 10, 2026, 4:59 PM CET
Embla Medical Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 984.45 | 928.69 | 854.89 | 785.68 | 718.65 | 718.67 |
Revenue Growth | 12.70% | 8.63% | 8.81% | 9.33% | -0.00% | 14.16% |
Gross Profit Gross Profit Growth | 613.39 | 578.56 | 534.7 | 485.57 | 439.75 | 455.39 |
Operating Income Operating Income Growth | 133.8 | 124.7 | 112.75 | 87.46 | 67.14 | 95.62 |
Net Income Net Income Growth | 93.95 | 83.34 | 68.28 | 58.39 | 42.51 | 63.99 |
Earnings Per Share EPS Growth | 0.22 | 0.20 | 0.16 | 0.14 | 0.10 | 0.15 |
EPS Growth | 27.19% | 21.96% | 15.20% | 36.53% | -32.78% | 929.72% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Prosthetics & Neuro Orthotics Prosthetics & Neuro Orthotics Growth | 563.4 | 513.41 | 451.31 | 394.84 | 346.52 | 452.77 |
Bracing and Supports (Incl.Compression Therapy (Phlebology)) Bracing and Supports (Incl.Compression Therapy (Phlebology)) Growth | 151.33 | 148.38 | 148.39 | 146.5 | 143.12 | 265.9 |
Internal Product Sales Internal Product Sales Growth | -41.42 | -39.04 | -38.52 | -35.75 | -31.08 | - |
Patient Care Patient Care Growth | 311.15 | 305.93 | 293.71 | 280.1 | 260.09 | - |
Total Total Growth | 984.45 | 928.69 | 854.89 | 785.69 | 718.65 | 718.67 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 98.78 | 102.51 | 86.16 | 72.65 | 76.63 | 85.2 |
Total Debt Total Debt Growth | 533.97 | 541.57 | 499.79 | 467.73 | 480.92 | 448.15 |
Net Cash (Debt) Net Cash Growth | -435.2 | -439.06 | -413.63 | -395.08 | -404.29 | -362.95 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -1.01 | -1.03 | -0.97 | -0.94 | -0.97 | -0.86 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 142.95 | 132.62 | 116.07 | 94.32 | 60.77 | 100.53 |
Capital Expenditures CapEx Growth | -17.01 | -22.07 | -27.03 | -29.23 | -16.55 | -16.96 |
Free Cash Flow Free Cash Flow Growth | 125.93 | 110.55 | 89.03 | 65.09 | 44.22 | 83.57 |
Free Cash Flow Growth | 27.86% | 24.16% | 36.78% | 47.19% | -47.08% | 6.50% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 62.31% | 62.30% | 62.55% | 61.80% | 61.19% | 63.37% |
Operating Margin | 13.59% | 13.43% | 13.19% | 11.13% | 9.34% | 13.31% |
Pretax Margin | 12.38% | 11.62% | 10.59% | 9.67% | 7.82% | 12.06% |
Profit Margin | 9.54% | 8.97% | 7.99% | 7.43% | 5.92% | 8.91% |
FCF Margin | 12.79% | 11.90% | 10.42% | 8.29% | 6.15% | 11.63% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 20.63 | 26.20 | 30.90 | 29.30 | 47.64 | 42.69 |
Forward PE | 17.94 | 22.07 | 23.84 | 22.12 | 26.05 | 32.70 |
P/FCF Ratio | 15.27 | 19.75 | 23.70 | 26.29 | 45.80 | 32.69 |
PS Ratio | 1.95 | 2.35 | 2.47 | 2.18 | 2.82 | 3.80 |